Agenda 2007
| Day | Time | Session | |
|---|---|---|---|
| Wednesday, November 28 | 08:00 | Conference Registration/Hospitality Desk Opens | |
| Wednesday, November 28 | 08:00 - 09:00 | Registration and Breakfast | |
| Wednesday, November 28 | 09:00 - 10:10 |
General Session: Opening Remarks and Keynote Speaker
|
|
| Wednesday, November 28 | 10:10 - 13:30 | Parallel Sessions | |
| Wednesday, November 28 | 10:10 - 11:00 |
Global State of ICT PRESENTOR:
|
|
| Wednesday, November 28 | 10:10 - 11:00 |
Global State of Biotechnology PRESENTOR:
|
|
| Wednesday, November 28 | 11:00 - 11:30 | Coffee Break | |
| Wednesday, November 28 | 11:30 - 12:30 |
ICT Panel 1: Mobile Broadband Panel It is predicted that nearly half of the handsets will be broadband-capable by 2010. This creates a new generation of consumers who value mobility above all else when it comes to telecommunication services. Applications such as video, gaming, and a wealth of new services are competing to run on your personal communication device. Mobile broadband promises to meet the needs of these consumers as well as the service providers. Competing technologies ranging from WiMax and3GPP to those beyond 3G are claiming to be the vehicle of choice for the next generation consumers and their favorite services. This panel will evaluate the underlying technologies behind mobile broadband as well as the array of new services which can be delivered over this infrastructure. It will examine governmental, economic and structural issues of the sector and how they may affect the introduction of new technologies and services. MODERATOR:
|
|
| Wednesday, November 28 | 11:30 - 12:30 |
Life Sciences Panel 1: White Biotechnology (Industrial, Food and Agriculture, Environmental) The world population has increased from 3 billion in 1959 to 6 billion in 1999 and is expected to grow to 9 billion by the year 2042. With this rapid growth, there has also been an increase in the per capita income globally, especially in such areas as China and India resulting in a significantly higher demand for food products. However, rural and agricultural land is decreasing due to urban development, thus requiring global improvements in efficiencies in agricultural practices. In addition, with diminishing fossil fuel resources, nations are trying to find alternative sources such as bio-based diesel fuels to minimize the contribution of fossil fuel to climate change. McKinsey & Company have estimated that biotechnology could be applied in the production of 10% to 20% of all chemicals sold by 2010, starting from the current level of about 5%. While different chemical markets introduce and use biotechnology at different rates, the McKinsey study indicates the greatest impact of industrial biotechnology will be on the fine chemical segment, where up to 60% of products may use biotechnology by 2010. McKinsey have further estimated that between 11 & 22 billion Euro additional added value could be created by the chemical industry alone in 2010, through cost reduction and the introduction of novel products. In this panel, opportunities in food and agriculture and bio-industrial products to address these growing needs will be discussed. MODERATOR:
|
|
| Wednesday, November 28 | 12:30 - 13:30 |
ICT Panel 2: Digital content: Creation, Access and Distribution Digital content is increasingly important across all media and publishing industries and is becoming pervasive in sectors not previously considered to be content producers or users (for example, business services) and in the public sector (public sector information such as weather information, public sector content such as archives, and cultural content), education and health. Rapid changes in the value chains for content development, production, delivery and use and the creation of new commercial business models to exploit these opportunities are posing new policy challenges for governments to provide the market and business environment that supports development of new digital content goods and services, promotes competition and benefits users. In addition, it is important to understand dynamic impact of broadband rollout, its effects on content creation and distribution, and the implications for creativity, economic growth and employment and provide an overview of emerging developments. In addition, with digital content opportunities and challenges, we need to understand changing value chains and business models. Lastly, new platforms and content delivery opportunities and the Creation and access to content and the role of new commercial agreements and user-side perspectives such as new user habits and social attitudes and Enhanced access to research and public sector information will be discussed in the session (web 2.0) This panel provides a forum for all stakeholders to draw on this analysis as a basis for discussing policy developments and solutions to emerging technology and policy challenges, and identify issues for further analysis. It focused on:
|
|
| Wednesday, November 28 | 12:30 - 13:30 |
Life Sciences Panel 2: Health and Wellness The cost of healthcare and treatment of disease is ballooning world-wide. Preventive medicine through a variety of means including appropriate and customized nutrition is gaining widespread acceptance. Access to the internet and availability of information offer consumers the ability to actively participate in their choice of health and wellness products and services. As a result, new and expanding markets are opening for innovative health and wellness products and services. Nutrition and health and wellness products offer great opportunities to help all demographic segments to improve their health and enjoy a desired life style. There is considerable growth potential within the health and wellness industry resulting from the convergence of the $700 billion food and beverage industry and the $150 billion pharmaceutical industry, influenced by consumer trends in exercise, healthy lifestyles and nutrition, and galvanized by paradigm shifts in consumer attitudes toward wellness and disease. This panel discussion will focus on opportunities in health and wellness. MODERATOR:
|
|
| Wednesday, November 28 | 13:30 - 15:00 | Buffet Lunch and Networking | |
| Wednesday, November 28 | 15:00 - 18:00 | Parallel sessions: Boot camp (for entrepreneurs) and Convergence: Investing in Spain (for investors) | |
| Wednesday, November 28 | 15:00 - 16:15 |
Workshop 1E: How to go about launching your idea successfully Venture Capital firms are flushed with money and want to put it to work. You believe your latest idea will change the world as we know it. A match made in heaven? No problem? Not so fast!. There are thousands of entrepreneurs churning business plans that never get funded or even reviewed by the VCs. What are they looking for? How should you prepare to make an impression on them? The presenters in this session, One VC and One Entrepreneur will share their thoughts on how to go about launching your idea successfully. You will learn about various stages of starting your business such as testing your idea, building a winning team, selecting the right VCs, understanding the VC lingo, writing a business plan, negotiating with VC, selecting a board and leveraging the vast network of your VCs. MODERATOR:
|
|
| Wednesday, November 28 | 15:00 - 16:15 |
Silicon Valley-Catalonia Convergence 1: Investing in Catalonia & Spain is a safe bet The business and regulatory climate in Catalonia and Spain (Policy Framework, Incentives and Regulations, etc.) will be analyzed and debated by experts in the field. MODERATOR:
|
|
| Wednesday, November 28 | 16:15 - 16:45 | Coffee Break | |
| Wednesday, November 28 | 16:45 - 18:00 |
Workshop 2E: All about financing companies This workshop session will feature one Angel/Venture Capital investor and one start-up entrepreneur who will describe their experiences in financing start-up companies and how to prepare the start-up for initial funding. The Angel/Venture Capital investor will describe what seed investors are looking for in a new company and some of the screening mechanisms that Angels and VCs use. The experienced start-up entrepreneur will describe the search for seed capital and what a start-up executive might expect during the interactions with Angels and/or VCs. After brief presentations from the workshop leaders, they will take questions from the audience. MODERATOR:
|
|
| Wednesday, November 28 | 16:45 - 18:00 |
Silicon Valley-Catalonia Convergence 2: Establishing transatlantic partnerships How venture capitalists from the United States can find strategic partners to reduce their investments risks in the regions where they don’t want to invest on infrastructure. Local venture capitalists can also learn about how investments are being done from a US stand point. MODERATOR:
|
|
| Thursday, November 29 | 08:00 | Conference Registration/Hospitality Desk Opens | |
| Thursday, November 29 | 08:00 - 09:00 | Registration and Breakfast | |
| Thursday, November 29 | 09:00 - 10:00 |
ICT Panel 3: Next generation Internet In this panel we use the Internet as our primary vehicle for discussing next generation networks and their architectures. Today’s Internet is evolving at a rapid pace with advances being made on many fronts ranging from deploying new applications and services to implementing advanced technologies. And much more are yet to unfold. We narrow our discussion to how we would design the Internet if we were to architect it today to meet the needs of new applications including the popular P2P networking (Napster, BitTorrent, Skype), Web2.0 mass collaboration (Wikis/ Wikipedia, blogs, MySpace social networking YouTube video sharing, user generated content and distribution), and friendly e-commerce just to name a few. We will also cover the important issues of regulation, public policy, and competition as related to the business aspects of building the next generation Internet. MODERATOR:
|
|
| Thursday, November 29 | 09:00 - 10:00 |
Life Sciences Panel 3: Health Medicine On average, therapeutics cost at least $800M in research and development prior to reaching the market. Many candidates fail to make it through the development process, contributing to this high cost. In addition, drugs can be approved and then withdrawn due to safety concerns. Ideally drugs should be perfect, safe and cheap, but perfection and safety come at a price. Making drugs 100% safe for a genetically diverse population is a tough task, yet the benefits of a drug to the majority can be outweighed by harm, real or perceived, to a very few. It is clear that the cost of successfully bringing drugs to the market needs to be reduced. Therefore, many companies globally are approaching disease treatment through the fields of medical diagnostics and medical devices. With the sequencing of genomes, including human genome, there are exciting opportunities in molecular diagnostics for application at site of treatment such as hospitals and military fields. Advances in medical devices have enabled earlier detection and prevention of cancer through the use of high-resolution endoscopy and chromoendoscopy among others, needle-free treatment of diabetes have improved general patient compliance as well as better quality of life, innovative use of plastics in such areas as hip and knee replacement have improved not only life expectancy in our population, but have also increased the qualify of life for the elderly. This panel will address innovative means for disease treatment that could be applied to a wide variety of fields such as infectious diseases, terrorism, border checking and trade, bio-terrorism, and food safety, among others. MODERATOR:
|
|
| Thursday, November 29 | 10:00 - 10:15 |
Global State of Energy SPEAKER:
|
|
| Thursday, November 29 | 10:15 - 11:15 |
Energy Panel: Investing in Clean Energy: What Silicon Valley and Spain Can Learn From Each Other Dollars have poured into clean energy deals in recent years, resulting in some stirring successes and notable failures. For this trends that shows no signs of abating, many questions remain unanswered:
A panel of venture capitalists and Spanish executives will tackles these issues and more. MODERATOR:
|
|
| Thursday, November 29 | 10:15 - 11:15 |
ICT Panel 4: Enterprise Software Unlike the front page attention Internet companies get from the media, the enterprise software companies tend to get sporadic coverage. As a consistently robust sector for venture investors, software industry seems to be at crossroads. Salesforce, Inc. certainly proved the attractiveness and viability of the Software-as-a-Service (SaaS) model in a proven CRM space. SaaS’s expansion will be further bolstered by much anticipated IPOs of NetSuite and SuccessFactors. On the virtualization front, VMWare’s IPO is setting new standards and clearly prompted the $500M acquisition of XenSource which itself underlines the compelling value of both virtualization and Open Source solutions. The Software Panel will discuss the trends and dynamics of the Internet SW industry, explore what innovations may drive the next set of SW solutions and investment opportunities, debate whether the software industry is transitioning from a “growth” to “value”, as well as other megatrends that are monitored MODERATOR:
|
|
| Thursday, November 29 | 11:15 - 11:45 | Coffee Break | |
| Thursday, November 29 | 11:45 - 14:00 |
6 Minutes of Fame: Presentations to private investors and venture capitalists (Part 1) |
|
| Thursday, November 29 | 14:00 - 16:00 | Lunch and keynote (Dinar Cambra)
“What makes Silicon Valley unique; how to create an environment for innovation and economic growth in other emerging regions?”
|
|
| Thursday, November 29 | 16:15 - 18:15 |
6 Minutes of Fame: Presentations to private investors and venture capitalists (Part 2) |
|
| Thursday, November 29 | 18:15 - 19:30 | Free time | |
| Thursday, November 29 | 19:30 - 20:00 | Cocktail Reception | |
| Thursday, November 29 | 20:00 - 23:00 |
Awards Ceremony and Dinner: Awarding 6 Spanish Companies in Early stage, Mezzanine, Public, 3 in 2 tracks of ICT and Life Science
|
|